Publisher： Bentham Science Publishers
E-ISSN： 1873-4316|2|4|327-339
ISSN： 1389-2010
Source： Current Pharmaceutical Biotechnology, Vol.2, Iss.4, 2001-12, pp. : 327-339
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
B-cell lymphoma vaccination may benefit certain patients with NHL
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
Access to resources
Recommend
Denileukin diftitox effective in relapsed/refractory B-cell NHL
Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. :
Pharmacotherapy of large B-cell lymphoma
By Escalón Maricer P Lossos Izidore S
Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. :
Increasing complexity of high-grade B-cell lymphomas
By Armitage James O. Bociek R. Gregory
Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. :
To make antibodies or not: signaling by the B-cell antigen receptor
By Gold M.R.
Trends in Pharmacological Sciences, Vol. 23, Iss. 7, 2002-07 ,pp. :